Predict your next investment

See what CB Insights has to offer

Investments

1

About Veracity

Veracity Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Veracity News

Veracity Selfcare, Which Uses An At-Home Saliva Test To Guide Skincare Purchases, Secures $5M In Seed Funding

Sep 14, 2021

Veracity Selfcare, Which Uses An At-Home Saliva Test To Guide Skincare Purchases, Secures $5M In Seed Funding Share this article Personalization and hormone health are two of the hottest trends in beauty and wellness. Veracity Selfcare harnesses the power of both, and investors have taken notice. The 3-month-old skincare brand, which uses an at-home saliva test to understand the skin conditions of its customers, has secured $5 million in seed funding on top of $900,000 in pre-seed funding the company raised in 2020 and founder Allie Egan’s investment of $30,000. Briogeo founder Nancy Twine has participated in Veracity’s two rounds as an angel investor. “So much of what you see on the outside manifests from what’s happening on the inside,” she says. “Veracity has the potential to disrupt customized skincare with insightful wellness and health knowledge that drives bespoke skincare solutions rooted in clean and efficacious ingredients.” Egan left her position as CEO of women’s fashion brand Cynthia Rowley soon after the pandemic hit to launch Veracity. She’d been mulling over the idea for the brand since 2017, when stubborn skin issues led to a Hashimoto’s disease diagnosis and sparked Egan’s epiphany that issues manifesting externally can be signs of deeper health problems. Veracity debuted its $149 at-home Skin + Health hormone spit test in February. In June, it premiered six skincare products such as the concentrates Brightening Support, Inflammation Response and Hydration Balance priced from $55 to $85. In June, Veracity Selfcare premiered six skincare products such as the concentrates Inflammation Response, Brightening Support and Hydration Balance priced from $55 to $85. While she didn’t share Veracity’s sales figures, Egan says she’s been overwhelmed by the response to the brand and its mission from the press, influencers and consumers. “There’s been a big recognition that hormonal health and this whole health approach to skincare that we’re taking is new and different and needed,” she remarks. “It’s not just a trend, it’s a need. So many people are really interested in getting to understand what’s going on in their body, and how that’s driving their skin and broader health.” In its initial months on the market, Veracity’s customer base has begun to take shape. It encompasses a wide swath of women from 18 year olds in the throes of hormonal acne up to post-menopausal women in their 70s who are feeling the effects of a lack of estrogen and progesterone that impacts skin in numerous ways. Veracity’s core customers, though, are women in their 30s and 40s. Egan says, “I very much did not want to build a vertical platform around pregnancy or menopause or whatever because it’s not about this one specific hormonal imbalance.”  “Veracity is leading a movement to transform how women engage, discuss and understand beauty through the lens of their personal hormonal journey.” The proceeds from the seed raise will go toward product development, including the development of targeted facial skincare solutions to tackle skincare concerns like dark circles and inflammation. Veracity is slated to expand beyond facial skincare by early 2022. The expansion could include ingestible products and others designed to support health. Veracity’s product development process takes significant investments of time and money because it custom develops formulas with medical experts. The brand’s investors appreciate its approach. “Veracity is leading a movement to transform how women engage, discuss and understand beauty through the lens of their personal hormonal journey,” says Sarra Zayani, partner at Global Founders Capital. “We’re excited to see Veracity’s data-driven and horizontal approach pave the way in empowering consumers to uncover the truth and make informed decisions for their skin and overall health.” Share this article

Veracity Investments

1 Investments

Veracity has made 1 investments. Their latest investment was in Network Optix as part of their Seed on November 11, 2011.

CBI Logo

Veracity Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/29/2011

Seed

Network Optix

$0.75M

Yes

Date

11/29/2011

Round

Seed

Company

Network Optix

Amount

$0.75M

New?

Yes

Co-Investors

Sources

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.